Category: Latest News
-
Micron Forecasts First-Quarter Revenue Above Expectations on AI Demand
Micron Technology (NASDAQ:MU) forecast fiscal first-quarter 2027 revenue and adjusted earnings above analyst expectations, citing continued demand for memory products used in artificial intelligence infrastructure. Micron shares were slightly lower in US premarket trading. The company forecast first-quarter revenue of $61.5 billion, plus or minus $1.5 billion, compared with an analyst consensus of $56.77 billion.…
-
Gold Edges Lower as Treasury Yields and Dollar Offset Softer US Inflation Data
Gold prices moved slightly lower on Thursday as investors assessed softer US inflation data alongside elevated Treasury yields and a stronger dollar. At 04:46 ET (08:46 GMT), spot gold was down 0.1% at $4,152.98 an ounce, while gold futures declined 0.1% to $4,182.67 an ounce. The US Dollar Index, which measures the currency against a…
-
Oil Prices Rise as Markets Assess Middle East Supply and Diplomatic Developments
Oil prices moved higher on Thursday as traders assessed signs of recovering crude exports from the Middle East alongside uncertainty surrounding diplomatic efforts to end the regional conflict. Brent crude futures for December rose 2.0% to $100.03 a barrel by 04:26 ET (08:26 GMT), while US West Texas Intermediate crude futures gained 2.2% to $92.37…
-
US Futures Mixed as Micron Outlook and Nike Results Take Focus: Dow Jones, S&P, Nasdaq, Wall Street
US stock futures were mixed on Thursday ahead of the first trading session of the fourth quarter, with investors assessing higher Treasury yields, Micron’s (NASDAQ:MU) latest outlook and upcoming economic data. At 03:34 ET (07:34 GMT), Dow futures were down 219 points, or 0.4%, while S&P 500 futures gained 4 points, or 0.1%. Nasdaq 100…
-
Wall Street Fades After Cooler Inflation Reading as Dow and S&P 500 Post September Losses
U.S. stocks finished mixed on Wednesday after an early rally on softer inflation data lost steam. The Dow Jones Industrial Average and S&P 500 closed lower and ended September with monthly losses, while the Nasdaq Composite held a modest gain. Investors weighed a cooler-than-expected inflation report against rising Treasury yields and higher oil prices, with…
-
Wanderport Advances Issuer Works Beta as AI Strategy and Capital Restructuring Take Shape
Wanderport is preparing an early beta launch of its AI-powered Issuer Works platform while pursuing debt restructuring, physical AI opportunities and potential strategic acquisitions. Key Investor Takeaways Why WDRP Stock Is in Focus Wanderport provided an update covering its AI product strategy, the approaching beta launch of Issuer Works and planned changes to its capital…
-
Roche’s Fenebrutinib Receives FDA Priority Review for Relapsing and Primary Progressive Multiple Sclerosis
The FDA has accepted fenebrutinib for priority review across two forms of multiple sclerosis following three Phase III studies, moving Roche toward a potential expansion of its MS portfolio beyond Ocrevus. Key Investor Takeaways Why RHHBY Stock Is in Focus Genentech said the FDA has accepted its New Drug Application for fenebrutinib under priority review…
-
Frequency Holdings Activates $5 Million Zero-Dilution Growth Facility With $153,000 ReachOut Customer Agreement
Frequency Holdings has begun using ReachOut Digital Intelligence’s new Capchase Pay facility, converting a multi-year customer agreement into upfront cash without issuing equity or adding debt at the parent-company level. Key Investor Takeaways Why FRQN Stock Is in Focus Frequency Holdings has activated the $5 million financing capacity secured by its wholly owned ReachOut Digital…
-
Connect Biopharma Reports Positive Phase 2 Rademikibart COPD Data, Plans FDA Talks on Phase 3 Program
Rademikibart significantly reduced treatment failure and new moderate-to-severe COPD exacerbations in the Seabreeze STAT study, while Connect Biopharma said it plans to discuss a Phase 3 registrational program with the FDA. Key Investor Takeaways Why CNTB Stock Is in Focus Connect Biopharma reported preliminary topline results from its randomized, double-blind, placebo-controlled Phase 2 Seabreeze STAT…
-
Sono-Tek Secures Record $7.19 Million Clean Energy Order, Boosting Fiscal 2028 Backlog Visibility
Sono-Tek’s largest aggregate customer order to date covers 10 production-scale coating systems, adding to more than $10.79 million of backlog across two major programs expected primarily to ship during fiscal 2028. Key Investor Takeaways Why SOTK Stock Is in Focus Sono-Tek has secured approximately $7.19 million of orders from an existing clean energy customer, comprising…